N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one

C135H295N29O21 — CID 157229740

IUPACN-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one
SMILESCC.CC.CC.CC(C)CC(=O)N(C)CCN.CC(C)CC(=O)N1CCCNCC1.CC(C)CC(=O)NCCN.CC(C)CC(N)=O.CCC(=O)N(C)CCCN.CCC(=O)N(C)CCNC.CCC(=O)N(C)CCOC.CCC(=O)N1CCCCC1.CCC(=O)N1CCN(C)CC1.CCC(=O)N1CCOCC1.CCC(=O)NC1CCNCC1.CCC(=O)NCCCN.CCC(=O)NCCCNC.CCC(=O)NCCN(C)C.CCC(=O)NCCOC.CCNC(=O)CC(C)C.CNC(=O)CC(C)C.CNCCNC(=O)CC(C)C
InChIInChI=1S/C10H20N2O.2C8H16N2O.2C8H18N2O.C8H15NO.5C7H16N2O.C7H13NO2.C7H15NO2.C7H15NO.C6H14N2O.C6H13NO2.C6H13NO.C5H11NO.3C2H6/c1-9(2)8-10(13)12-6-3-4-11-5-7-12;1-3-8(11)10-6-4-9(2)5-7-10;1-2-8(11)10-7-3-5-9-6-4-7;1-7(2)6-8(11)10(3)5-4-9;1-7(2)6-8(11)10-5-4-9-3;1-2-8(10)9-6-4-3-5-7-9;1-6(2)5-7(10)9-4-3-8;1-4-7(10)8-5-6-9(2)3;1-4-7(10)9(3)6-5-8-2;1-3-7(10)9(2)6-4-5-8;1-3-7(10)9-6-4-5-8-2;1-2-7(9)8-3-5-10-6-4-8;1-4-7(9)8(2)5-6-10-3;1-4-8-7(9)5-6(2)3;1-2-6(9)8-5-3-4-7;1-3-6(8)7-4-5-9-2;1-5(2)4-6(8)7-3;1-4(2)3-5(6)7;3*1-2/h9,11H,3-8H2,1-2H3;3-7H2,1-2H3;7,9H,2-6H2,1H3,(H,10,11);7H,4-6,9H2,1-3H3;7,9H,4-6H2,1-3H3,(H,10,11);2-7H2,1H3;6H,3-5,8H2,1-2H3,(H,9,10);4-6H2,1-3H3,(H,8,10);8H,4-6H2,1-3H3;3-6,8H2,1-2H3;8H,3-6H2,1-2H3,(H,9,10);2-6H2,1H3;4-6H2,1-3H3;6H,4-5H2,1-3H3,(H,8,9);2-5,7H2,1H3,(H,8,9);3-5H2,1-2H3,(H,7,8);5H,4H2,1-3H3,(H,7,8);4H,3H2,1-2H3,(H2,6,7);3*1-2H3
InChIKeyATYPZJCNRNXXPG-UHFFFAOYSA-N
MW2661.03 g/mol
LogP10.42
Rot. Bonds56

About N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one

N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one (PubChem CID 157229740) has the molecular formula C135H295N29O21 and a molecular weight of 2661.03 g/mol. Its IUPAC name is N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one.

Molecular Properties

Compound NameN-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one
PubChem CID157229740
Molecular FormulaC135H295N29O21
Molecular Weight2661.03 g/mol
Exact Mass2659.29
IUPAC NameN-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one
SMILESCC.CC.CC.CC(C)CC(=O)N(C)CCN.CC(C)CC(=O)N1CCCNCC1.CC(C)CC(=O)NCCN.CC(C)CC(N)=O.CCC(=O)N(C)CCCN.CCC(=O)N(C)CCNC.CCC(=O)N(C)CCOC.CCC(=O)N1CCCCC1.CCC(=O)N1CCN(C)CC1.CCC(=O)N1CCOCC1.CCC(=O)NC1CCNCC1.CCC(=O)NCCCN.CCC(=O)NCCCNC.CCC(=O)NCCN(C)C.CCC(=O)NCCOC.CCNC(=O)CC(C)C.CNC(=O)CC(C)C.CNCCNC(=O)CC(C)C
InChIInChI=1S/C10H20N2O.2C8H16N2O.2C8H18N2O.C8H15NO.5C7H16N2O.C7H13NO2.C7H15NO2.C7H15NO.C6H14N2O.C6H13NO2.C6H13NO.C5H11NO.3C2H6/c1-9(2)8-10(13)12-6-3-4-11-5-7-12;1-3-8(11)10-6-4-9(2)5-7-10;1-2-8(11)10-7-3-5-9-6-4-7;1-7(2)6-8(11)10(3)5-4-9;1-7(2)6-8(11)10-5-4-9-3;1-2-8(10)9-6-4-3-5-7-9;1-6(2)5-7(10)9-4-3-8;1-4-7(10)8-5-6-9(2)3;1-4-7(10)9(3)6-5-8-2;1-3-7(10)9(2)6-4-5-8;1-3-7(10)9-6-4-5-8-2;1-2-7(9)8-3-5-10-6-4-8;1-4-7(9)8(2)5-6-10-3;1-4-8-7(9)5-6(2)3;1-2-6(9)8-5-3-4-7;1-3-6(8)7-4-5-9-2;1-5(2)4-6(8)7-3;1-4(2)3-5(6)7;3*1-2/h9,11H,3-8H2,1-2H3;3-7H2,1-2H3;7,9H,2-6H2,1H3,(H,10,11);7H,4-6,9H2,1-3H3;7,9H,4-6H2,1-3H3,(H,10,11);2-7H2,1H3;6H,3-5,8H2,1-2H3,(H,9,10);4-6H2,1-3H3,(H,8,10);8H,4-6H2,1-3H3;3-6,8H2,1-2H3;8H,3-6H2,1-2H3,(H,9,10);2-6H2,1H3;4-6H2,1-3H3;6H,4-5H2,1-3H3,(H,8,9);2-5,7H2,1H3,(H,8,9);3-5H2,1-2H3,(H,7,8);5H,4H2,1-3H3,(H,7,8);4H,3H2,1-2H3,(H2,6,7);3*1-2H3
InChIKeyATYPZJCNRNXXPG-UHFFFAOYSA-N
XLogP10.42
TPSA665.87 Ų
H-Bond Donors19
H-Bond Acceptors32
Rotatable Bonds56
Heavy Atoms185
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002661.03
LogP ≤ 510.42
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one?
The IUPAC name of N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one (CID 157229740) is N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one.
What is the SMILES notation for N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one?
The canonical SMILES for N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one is CC.CC.CC.CC(C)CC(=O)N(C)CCN.CC(C)CC(=O)N1CCCNCC1.CC(C)CC(=O)NCCN.CC(C)CC(N)=O.CCC(=O)N(C)CCCN.CCC(=O)N(C)CCNC.CCC(=O)N(C)CCOC.CCC(=O)N1CCCCC1.CCC(=O)N1CCN(C)CC1.CCC(=O)N1CCOCC1.CCC(=O)NC1CCNCC1.CCC(=O)NCCCN.CCC(=O)NCCCNC.CCC(=O)NCCN(C)C.CCC(=O)NCCOC.CCNC(=O)CC(C)C.CNC(=O)CC(C)C.CNCCNC(=O)CC(C)C.
What is the InChIKey of N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one?
The InChIKey is ATYPZJCNRNXXPG-UHFFFAOYSA-N. The full InChI is InChI=1S/C10H20N2O.2C8H16N2O.2C8H18N2O.C8H15NO.5C7H16N2O.C7H13NO2.C7H15NO2.C7H15NO.C6H14N2O.C6H13NO2.C6H13NO.C5H11NO.3C2H6/c1-9(2)8-10(13)12-6-3-4-11-5-7-12;1-3-8(11)10-6-4-9(2)5-7-10;1-2-8(11)10-7-3-5-9-6-4-7;1-7(2)6-8(11)10(3)5-4-9;1-7(2)6-8(11)10-5-4-9-3;1-2-8(10)9-6-4-3-5-7-9;1-6(2)5-7(10)9-4-3-8;1-4-7(10)8-5-6-9(2)3;1-4-7(10)9(3)6-5-8-2;1-3-7(10)9(2)6-4-5-8;1-3-7(10)9-6-4-5-8-2;1-2-7(9)8-3-5-10-6-4-8;1-4-7(9)8(2)5-6-10-3;1-4-8-7(9)5-6(2)3;1-2-6(9)8-5-3-4-7;1-3-6(8)7-4-5-9-2;1-5(2)4-6(8)7-3;1-4(2)3-5(6)7;3*1-2/h9,11H,3-8H2,1-2H3;3-7H2,1-2H3;7,9H,2-6H2,1H3,(H,10,11);7H,4-6,9H2,1-3H3;7,9H,4-6H2,1-3H3,(H,10,11);2-7H2,1H3;6H,3-5,8H2,1-2H3,(H,9,10);4-6H2,1-3H3,(H,8,10);8H,4-6H2,1-3H3;3-6,8H2,1-2H3;8H,3-6H2,1-2H3,(H,9,10);2-6H2,1H3;4-6H2,1-3H3;6H,4-5H2,1-3H3,(H,8,9);2-5,7H2,1H3,(H,8,9);3-5H2,1-2H3,(H,7,8);5H,4H2,1-3H3,(H,7,8);4H,3H2,1-2H3,(H2,6,7);3*1-2H3.
What are the key properties of N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one?
N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one has a molecular weight of 2661.03 g/mol, XLogP of 10.42, 56 rotatable bonds, 19 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-aminoethyl)-N,3-dimethylbutanamide;N-(2-aminoethyl)-3-methylbutanamide;N-(3-aminopropyl)-N-methylpropanamide;N-(3-aminopropyl)propanamide;1-(1,4-diazepan-1-yl)-3-methylbutan-1-one;N-[2-(dimethylamino)ethyl]propanamide;N,3-dimethylbutanamide;ethane;N-ethyl-3-methylbutanamide;N-(2-methoxyethyl)-N-methylpropanamide;N-(2-methoxyethyl)propanamide;N-[3-(methylamino)propyl]propanamide;3-methylbutanamide;3-methyl-N-[2-(methylamino)ethyl]butanamide;N-methyl-N-[2-(methylamino)ethyl]propanamide;1-(4-methylpiperazin-1-yl)propan-1-one;1-morpholin-4-ylpropan-1-one;N-piperidin-4-ylpropanamide;1-piperidin-1-ylpropan-1-one is sourced from PubChem (CID 157229740), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).